Lonestar Capital Management’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-46,965
Closed -$564K 24
2020
Q4
$564K Sell
46,965
-169,435
-78% -$2M 0.1% 22
2020
Q3
$2.16M Sell
216,400
-72,620
-25% -$874K 0.38% 21
2020
Q2
$3.02M Sell
289,020
-50,986
-15% -$567K 0.99% 15
2020
Q1
$3.64M Buy
340,006
+40,006
+13% +$485K 3.67% 10
2019
Q4
$4.75M Hold
300,000
2.86% 13
2019
Q3
$2.35M Buy
+300,000
New +$2.66M 0.78% 21

Other funds holding PRTA

Lonestar Capital Management's PRTA Position: Q1 2021 in Review

Lonestar Capital Management sold out of Prothena Corp (PRTA) in Q1 2021, closing a stake of 46,965 shares — an estimated $564K sold.

Lonestar Capital Management first reported a position in PRTA in Q3 2019 and held it in 6 quarters. The position peaked at $4.75M in Q4 2019. 146 funds tracked by Wall St. Rank hold PRTA as of Q1 2021.

  • Lonestar Capital Management reported no remaining Prothena Corp position as of Q1 2021 after selling out during the quarter.
  • Lonestar Capital Management sold 46,965 Prothena Corp shares in Q1 2021, an estimated $564K.
  • Lonestar Capital Management first reported a position in Prothena Corp in Q3 2019 and held it in 6 quarters.
  • Lonestar Capital Management's Prothena Corp position peaked at $4.75M in Q4 2019.
  • 146 funds tracked by Wall St. Rank held Prothena Corp as of Q1 2021.

Based on Lonestar Capital Management's 13F filing for Q1 2021, filed 14 May 2021.